Showing 1 - 2 results of 2 for search 'Kang-shuai Li', query time: 0.05s Refine Results
  1. 1
    Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma

    Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma by Kang-shuai Li, Yi Liu, Tie-zhong Zhang, Yun-fei Xu, Zong-li Zhang

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAIC

    Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAIC by Li-xin Du, Guo-li Sheng, An-da Shi, Kang-shuai Li, Zeng-li Liu, Yong-chang Tang, Yi Liu, Zong-li Zhang

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: